- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01360580
Swallowing Disorders After Prolonged Mechanical Ventilation (Deglutube)
January 23, 2013 updated by: University Hospital, Rouen
Current Care Study of Incidence and Consequences of Swallowing Disorders After Invasive Mechanical Ventilation
Epidemiology study for evaluation of incidence of swallowing disorders (SD) after prolonged invasive ventilation (more than seven days), using a clinical statement.
All consecutive patients are screened, and clinical evaluation is performed during 48h after patient's extubation.
If a SD exist, a new evaluation is realized 48h after.
Three groups will be created (1.no SD, 2.transitory SD and 3.persistent SD (eg persistent after 48h)).
Data complementary are notified at day 28 (pneumonia?
nutritional status?)
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
138
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Angers, France, 49933
- Service de Réanimation Médicale
-
Rouen, France, 76031
- Service de Réanimation Médicale
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
More than 7d of invasive mechanical ventilation
Description
Inclusion Criteria:
- More than 7 days of invasive mechanical ventilation
Exclusion Criteria:
- Age < 18 years old
- Preexistent swallowing disorders, stroke, tracheostomy
- Failure of patient's agreement
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Prevalence of swallowing disorders after prolonged invasive ventilation
Time Frame: 48 hours after extubation
|
48 hours after extubation
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Nutritional status at day 28
Time Frame: day 28
|
day 28
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gaetan Beduneau, Doctor, Service de Réanimation médicale Hôpitaux de Rouen
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (Actual)
February 1, 2012
Study Completion (Actual)
December 1, 2012
Study Registration Dates
First Submitted
May 24, 2011
First Submitted That Met QC Criteria
May 24, 2011
First Posted (Estimate)
May 25, 2011
Study Record Updates
Last Update Posted (Estimate)
January 24, 2013
Last Update Submitted That Met QC Criteria
January 23, 2013
Last Verified
January 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2009/110/HP
- 2008-A00057-50 (Other Identifier: Id RCB)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Larynx Disease
-
Mayo ClinicSuspendedLarynx | Larynx Disease | Laryngectomy | Larynx Stenosis | Larynx FractureUnited States
-
University of Texas Southwestern Medical CenterCompletedEarly-stage Glottic Larynx CancerUnited States
-
Latin American Cooperative Oncology GroupMerck Sharp & Dohme LLCActive, not recruitingSquamous Cell Carcinoma of LarynxBrazil
-
University of LeipzigUniversity of Kiel; University of Cologne; University of Jena; Technical University... and other collaboratorsRecruitingLaryngeal Cancer | Squamous Cell Carcinoma of Head and Neck | Laryngeal Neoplasms | Squamous Cell Carcinoma of the Larynx | Hypopharyngeal Squamous Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Laryngectomy; Status | Squamous Cell Carcinoma of Larynx | Squamous Cell Carcinoma of the Larynx Stage... and other conditionsGermany
-
Vanderbilt UniversityCompleted
-
Danish Head and Neck Cancer GroupCompletedHNSCC,Larynx, Pharynx and Oral CavityDenmark
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedHuman Papilloma Virus Infection | Stage III Squamous Cell Carcinoma of the Hypopharynx | Stage III Squamous Cell Carcinoma of the Larynx | Stage III Squamous Cell Carcinoma of the Oropharynx | Stage III Verrucous Carcinoma of the Larynx | Stage IV Squamous Cell Carcinoma of the Hypopharynx | Stage... and other conditionsUnited States
-
Hacettepe UniversityCompletedLarynx Cancer | Larynx CarcinomaTurkey
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedTongue Cancer | Stage III Squamous Cell Carcinoma of the Hypopharynx | Stage III Squamous Cell Carcinoma of the Larynx | Stage III Squamous Cell Carcinoma of the Oropharynx | Stage III Verrucous Carcinoma of the Larynx | Stage IV Squamous Cell Carcinoma of the Hypopharynx | Stage IVA Squamous... and other conditionsUnited States
-
Radboud University Medical CenterDutch Cancer SocietyCompleted